{"id":"NCT03054428","sponsor":"Regeneron Pharmaceuticals","briefTitle":"Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis","officialTitle":"A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Dupilumab Monotherapy in Patients ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-03-21","primaryCompletion":"2018-04-04","completion":"2018-06-05","firstPosted":"2017-02-15","resultsPosted":"2019-07-23","lastUpdate":"2019-07-23"},"enrollment":251,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Moderate-to-Severe Atopic Dermatitis","Dermatitis, Dermatitis Atopic","Eczema, Skin Diseases, Skin","Diseases Genetic, Genetic","Diseases Inborn, Skin","Disease, Eczematous Skin","Hypersensitivity, Immediate","Hypersensitivity, Immune System Diseases","Dermatitis, Atopic"],"interventions":[{"type":"DRUG","name":"Dupilumab","otherNames":["REGN668"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"EXPERIMENTAL"},{"label":"Dupilumab 300 mg Q4W","type":"EXPERIMENTAL"},{"label":"Dupilumab 200 mg or 300 mg Q2W","type":"EXPERIMENTAL"}],"summary":"The primary objective of the study was to demonstrate the efficacy of dupilumab as a monotherapy in participants ≥12 years to \\<18 years of age with moderate-to-severe atopic dermatitis (AD). The secondary objective of the study was to assess the safety of dupilumab as a monotherapy in participants ≥12 years to \\<18 years of age with moderate-to-severe AD.","primaryOutcome":{"measure":"Percentage of Participants With Investigator's Global Assessment (IGA) 0 or 1 (and Reduction From Baseline of ≥2 Points) at Week 16","timeFrame":"Baseline and Week 16","effectByArm":[{"arm":"Placebo","deltaMin":2.4,"sd":null},{"arm":"Dupilumab 300 mg Q4W","deltaMin":17.9,"sd":null},{"arm":"Dupilumab 200 mg or 300 mg Q2W","deltaMin":24.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"< 0.0001"},{"comp":"OG000 vs OG001","p":"= 0.0007"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":10},"locations":{"siteCount":45,"countries":["United States","Canada"]},"refs":{"pmids":["39588375","36723913","35567671","34427891","34270797","33655423","33481203","32135208","31823222","31693077","31641952","31595499"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":85},"commonTop":["Dermatitis atopic","Upper respiratory tract infection","Headache","Nasopharyngitis","Influenza"]}}